2-Bromopalmitate depletes lipid droplets to inhibit viral replication

By sjmartinez • April 17, 2024

Liu D, Cruz-Cosme R, Wu Y, Leibowitz J, Tang Q. 2-Bromopalmitate depletes lipid droplets to inhibit viral replication. J Virol. 2024 Apr 16;98(4):e0017124. doi: 10.1128/jvi.00171-24. Epub 2024 Mar 15. PMID: 38488361; PMCID: PMC11019840.

Tags: 2-bromopalmitate, Antiviral, coronavirus, General Internal Medicine, King Drew Med Ctr, lipid droplet, MHV-A59, palmitoylation, Publications

William J. Carroll, MD, FACP Appointed Section Chief of Palliative Care and Extensivist Medicine

The UCLA Department of Medicine (DoM) is pleased to announce the appointment of William J. Carroll, MD, FACPas section chief of the UCLA DoM Palliative Care[...]

Joshua N. Khalili, MD Appointed to DoM Chief Wellness Officer

The UCLA Department of Medicine has appointed Joshua N. Khalili, MD to chief wellness officer (CWO) effective April 1. The appointment builds on Dr. Khalili’s outstanding work[...]

Sun M. Yoo, MD, MPH to Depart DoM to Pursue New Leadership Opportunity

The UCLA Department of Medicine (DoM) announces that Sun M. Yoo, MD, MPH, will be departing UCLA Health to assume the role of a founding chief[...]